View More View Less
  • 1 National Institute of Rheumatology and Physiotherapy Budapest, Hungary
  • | 2 Central Immune Laboratory, Semmelweis University of Medicine Budapest, Hungary
  • | 3 Department of Genetics, Cell- and Immune Biology, Semmelweis University of Medicine Budapest, Hungary
  • | 4 Department of Genetics, Cell- and Immune Biology, Semmelweis University of Medicine Budapest, Hungary
  • | 5 Department of Genetics, Cell and Immunobiology Semmelweis University, Faculty of Medicine Nagyvárad tér 4, H-1089 Budapest, Hungary
Restricted access

In contrast to most of the soluble cytokine receptor antagonists properties, the soluble IL-6 receptor (sIL-6R) occurring in various body fluids of healthy persons and patients with various diseases is an agonist. The enhancing effect is due to its ability to form complex with IL-6 and to bind to gp130 making constitutively IL-6 receptor negative cells responsive for IL-6. The generation as well as the functional role of soluble IL-6 receptor is poorly understood. Earlier, we found that the sIL-6R levels in sera of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) were higher than those of the control group measured by ELISA sandwich technology. In the present study we detected different levels of sIL-6R in the supernatants of lymphocyte cultures of healthy persons and patients with RA as well as SLE. Moreover, we found, that in vitro dexamethasone treatment stimulated generation of sIL-6R in both healthy persons and in active SLE, while it strongly suppressed production of sIL-6R in both RA groups. At mRNA level, we found that in SLE both the IL-6R mRNA encoding the membrane spanning and alternatively spliced (soluble) variants increased. Surprisingly, the strong decrease of sIL6R protein in RA was not found at mRNA level.

  • Straub, R., H., Müller-Ladner, U., Lichtinger, T., Schölmerich, J., Menninger, H., Lang, B. (1997) Decrease of IL-6 during the first 12 months is prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs. Br. J. Rheumatol. 36, 1298-1303.

    'Decrease of IL-6 during the first 12 months is prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs ' () 36 Br. J. Rheumatol. : 1298 -1303.

    • Search Google Scholar
  • Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S. (1988) The ARA 1987. revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324.

    'The ARA 1987. revised criteria for the classification of rheumatoid arthritis ' () 31 Arthritis Rheum. : 315 -324.

    • Search Google Scholar
  • Bombardier, C., Gladman, D. D., Urowitz, M. B. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35, 630-640.

    'Derivation of the SLEDAI: a disease activity index for lupus patients ' () 35 Arthritis Rheum. : 630 -640.

    • Search Google Scholar
  • Chomezynski, P., Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-163.

    'Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction ' () 162 Anal. Biochem. : 156 -163.

    • Search Google Scholar
  • Falus, A., Lakatos, T., Smolen, J. (1992) Dissimilar biosynthesis of IL-6 by different areas of synovial membrane of patients with rheumatoid arhritis and osteoarthritis. Scand. J. Rheumatol. 21, 116-119.

    'Dissimilar biosynthesis of IL-6 by different areas of synovial membrane of patients with rheumatoid arhritis and osteoarthritis ' () 21 Scand. J. Rheumatol. : 116 -119.

    • Search Google Scholar
  • Gaillard, J. P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T., Klein, B. (1993) Increased and highly stable levels of functional soluble IL-6R in sera of patients with monoclonal gammopathy. Eur. J. Immunol. 23, 820-824.

    'Increased and highly stable levels of functional soluble IL-6R in sera of patients with monoclonal gammopathy ' () 23 Eur. J. Immunol. : 820 -824.

    • Search Google Scholar
  • Studnicka-Benke, A., Steiner, G., Petera, P., Smolen, J. S. (1996) Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br. J. Rheumatol. 35, 1067-1074.

    'Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus ' () 35 Br. J. Rheumatol. : 1067 -1074.

    • Search Google Scholar
  • Taga, T., Kishimoto, T. (1997) Gp 130 and the interleukin-6 family of cytokines. Ann. Rev. Immunol. 15, 797-819.

    'Gp 130 and the interleukin-6 family of cytokines ' () 15 Ann. Rev. Immunol. : 797 -819.

  • Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., Winchester, R. J. (1982) Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277.

    'Revised criteria for the classification of systemic lupus erythematosus ' () 25 Arthritis Rheum. : 1271 -1277.

    • Search Google Scholar
  • Yokoyama, A., Kohno, N., Fujino, S., Hamada, H., Inoue, Y., Fujioka, S., Ishida, S., Hiwada, K. (1995) Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases. Clin. Exp. Immunol. 100, 325-329.

    'Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases ' () 100 Clin. Exp. Immunol. : 325 -329.

    • Search Google Scholar
  • Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer-Büschenfelde, K. H., Rose-John, S. (1996) The function of the soluble IL-6 receptor in vivo sensitisation of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Medicine 184, 1399-1406.

    'The function of the soluble IL-6 receptor in vivo sensitisation of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6 ' () 184 J. Exp. Medicine : 1399 -1406.

    • Search Google Scholar
  • Polgár, A., Brózik, M., Tóth, S., Falus, A., Kádár, A., Hodinka, L. (2000) Soluble interleukin-6 receptor (sIL-6R) levels in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Medical Science Monitor 6, 13-18.

    'Soluble interleukin-6 receptor (sIL-6R) levels in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) ' () 6 Medical Science Monitor : 13 -18.

    • Search Google Scholar
  • Apostolakos, M. J., Schuermann, W. H., Frampton, M. W., Utell, M. J., Willey, J. C. (1993) Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal. Biochem. 213, 277-284.

    'Measurement of gene expression by multiplex competitive polymerase chain reaction ' () 213 Anal. Biochem. : 277 -284.

    • Search Google Scholar
  • Igaz, P., Toth, S., Rose-John, S., Madurka, I., Fejér, Gy., Szalai, Cs., Falus, A. (1998) Soluble interleukin-6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine 10, 620-626.

    'Soluble interleukin-6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes ' () 10 Cytokine : 620 -626.

    • Search Google Scholar
  • Igaz, P., Horváth, A., Horváth, B., Szalai, Cs., Pállinger, É., Rajnavölgyi, É., Tóth, S., Rose-John, S., Falus, A. (2000) Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunol. Lett. 71, 143-148.

    'Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production ' () 71 Immunol. Lett. : 143 -148.

    • Search Google Scholar
  • Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., Kishimoto, T. (1992) Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148, 2175-2180.

    'Human soluble IL-6 receptor: its detection and enhanced release by HIV infection ' () 148 J. Immunol. : 2175 -2180.

    • Search Google Scholar
  • Housiau, F. A., Devogelaer, J. P., van Damme, J. (1988) IL-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784-788.

    'IL-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides ' () 31 Arthritis Rheum. : 784 -788.

    • Search Google Scholar
  • Hagiwara, E., Gourley, M. F., Lee, S., Klinman, D. K. (1996) Disease severity in patients with SLE correlates with an increased ratio of IL-10: IFN-gamma-secreting cells in the peripheral blood. Arthritis Rheum. 39, 379-385.

    'Disease severity in patients with SLE correlates with an increased ratio of IL-10: IFN-gamma-secreting cells in the peripheral blood ' () 39 Arthritis Rheum. : 379 -385.

    • Search Google Scholar
  • Hirano, T., Matsuda, T., Nakajima, K. (1994) Signal transduction through gp-130 is shared among the receptors for the interleukin-6 related cytokine subfamily. Stem Cells 12, 262-277.

    'Signal transduction through gp-130 is shared among the receptors for the interleukin-6 related cytokine subfamily ' () 12 Stem Cells : 262 -277.

    • Search Google Scholar
  • Holub, M. C., Makó, E., Dévay, T., Dank, M., Szalai, Cs., Falus, A. (1998) Increased interleukin-6 levels, interleukin-6 receptor and gp 130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand. J. Gastroenterology 228, 47-50.

    'Increased interleukin-6 levels, interleukin-6 receptor and gp 130 expression in peripheral lymphocytes of patients with inflammatory bowel disease ' () 228 Scand. J. Gastroenterology : 47 -50.

    • Search Google Scholar
  • Holub, M. C., Szalai, Cs., Polgár, A., Fenyvesi, A., Tóth, S., Falus, A. (1999). Generation of "truncated" interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R. Immunol. Lett. 68, 121-124.

    () 68 Immunol. Lett. : 121 -124.

  • Kitani, A., Hara, M., Hirose, T., Harigai, M., Suzuki, K., Kawakami, M., Kawaguchi, Y., Hidaka, T., Kawagoe, M., Nakamura, H. (1992) Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: analysis of IL-6 production and IL-6R expression. Clin. Exp. Immunol. 88, 75-83.

    'Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: analysis of IL-6 production and IL-6R expression ' () 88 Clin. Exp. Immunol. : 75 -83.

    • Search Google Scholar
  • Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., Kohler, G. (1994) Impaired immune and acute phase responses in IL-6 deficient mice. Nature 368, 339-342.

    'Impaired immune and acute phase responses in IL-6 deficient mice ' () 368 Nature : 339 -342.

    • Search Google Scholar
  • Miyajima, A., Kitamura, T., Harada, N., Yokota, T., Arai, K. (1992) Cytokine receptors and signal transduction. Annual Rev. Immunol. 10, 295-339.

    'Cytokine receptors and signal transduction ' () 10 Annual Rev. Immunol. : 295 -339.

  • Nagafuchi, H., Suzuki, N., Mizuchima, Y., Sakane, T. (1993) Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with SLE. J. Immunol. 151, 6525-6534.

    'Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with SLE ' () 151 J. Immunol. : 6525 -6534.

    • Search Google Scholar
  • Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., Manolagas, S. C. (1992) Increased osteoclast development after estrogen loss: mediation by IL-6. Science 257, 88-91.

    'Increased osteoclast development after estrogen loss: mediation by IL-6 ' () 257 Science : 88 -91.

    • Search Google Scholar
  • Kishimoto, T. (1989) The biology of interleukin-6. Blood 74, 1-10.

    'The biology of interleukin-6 ' () 74 Blood : 1 -10.

  • Partsch, G., Wagner, E., Leeb, B. F., Dunky, A., Steiner, G., Smolen, J. S. (1998) Upregulation of cytokine receptors sTNF-R55, sTNF-R75 and sIL-2R in psoriatic arthritis synovial fluid. J. Rheumatol. 25, 105-110.

    'Upregulation of cytokine receptors sTNF-R55, sTNF-R75 and sIL-2R in psoriatic arthritis synovial fluid ' () 25 J. Rheumatol. : 105 -110.

    • Search Google Scholar

Editorial Board

      Csányi, Vilmos (Göd)
      Dudits, Dénes (Szeged)
      Falus, András (Budapest)
      Fischer, Ernő (Pécs)
      Gábriel, Róbert (Pécs)
      Gulya, Károly (Szeged)
      Gulyás, Balázs (Stockholm)
      Hajós, Ferenc (Budapest)
      Hámori, József (Budapest)
      Heszky, László (Gödöllő)
      Hideg, Éva (Szeged)
      E. Ito (Sanuki)
      Janda, Tibor (Martonvásár)
      Kavanaugh, Michael P. (Missoula)
      Kása, Péter (Szeged)
      Klein, Éva (Stockholm)
      Kovács, János (Budapest)
      Brigitte Mauch-Mani (Neuchâtel)
      Nässel, Dick R. (Stockholm)
      Nemcsók, János (Szeged)
      Péczely, Péter (Gödöllő)
      Roberts, D. F. (Newcastle-upon-Tyne)
      Sakharov, Dimitri A. (Moscow)
      Singh, Meharvan (Fort Worth)
      Sipiczky, Mátyás (Debrecen)
      Szeberényi, József (Pécs)
      Székely, György (Debrecen)
      Tari, Irma (Szeged)
      Vágvölgyi, Csaba (Szeged),
      L. Zaborszky (Newark)

 

Acta Biologica Hungarica
P.O. Box 35
H-8237 Tihany, Hungary
Phone: (36 87) 448 244 ext. 103
Fax: (36 87) 448 006
E-mail: elekes@tres.blki.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Current Contents: Agriculture
  • Biology and Environmental Sciences
  • Elsevier BIOBASE
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index
  • Science Citation Index Expanded (SciSearch)
  • SCOPUS
  • The ISI Alerting Services
  • Zoological Abstracts

 

Acta Biologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5383 (Print)
ISSN 1588-256X (Online)